Anemia
1,076
59
82
697
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
229 trials with published results (21%)
Research Maturity
697 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.2%
110 terminated out of 1076 trials
86.4%
-0.2% vs benchmark
33%
352 trials in Phase 3/4
33%
229 of 697 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 697 completed trials
Clinical Trials (1076)
Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes
ESA Hyporesponsiveness in Hemodialysis Patients
A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Study of DISC-0974-201 in Participants With IBD and Anemia
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients
Menstruation and Anemia Research: A Community Health Study
Effectiveness Study During the First 1,000 Days in Kenya
Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
Ferric Citrate in Iron Deficiency Anemia During Pregnancy
Impact of Iron Supplementation During Pregnancy
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
Patient Blood Management in Patients Scheduled for Cardiac Surgery
Perennial Malaria Chemoprevention (PMC) in Cameroon
Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire